Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 890.04M P/E - EPS this Y 32.00% Ern Qtrly Grth -
Income -67.06M Forward P/E -27.19 EPS next Y -13.00% 50D Avg Chg -2.00%
Sales 4.09M PEG -0.94 EPS past 5Y - 200D Avg Chg 91.00%
Dividend N/A Price/Book 4.44 EPS next 5Y 21.70% 52W High Chg -13.00%
Recommedations 2.60 Quick Ratio 12.46 Shares Outstanding 63.29M 52W Low Chg 3,763.00%
Insider Own 2.10% ROA -18.62% Shares Float 21.92M Beta -
Inst Own 103.43% ROE -37.23% Shares Shorted/Prior 1.16M/1.74M Price 14.68
Gross Margin 100.00% Profit Margin - Avg. Volume 419,328 Target Price 28.67
Oper. Margin -48,350.94% Earnings Date - Volume 499,565 Change -2.52%
About Ambrx Biopharma Inc.

Ambrx Biopharma Inc., a clinical stage biopharmaceutical company, focuses on discovering and developing antibody drug conjugates (ADCs) and other engineered therapies to modulate the immune system. It focuses on portfolio of clinical and preclinical programs designed to optimize efficacy and safety in multiple cancer indications, including ARX517, its proprietary antibody-drug conjugate (ADC) targeting the prostate-specific membrane antigen (PSMA) and ARX788, its proprietary ADC targeting HER2. The company also has preclinical and clinical collaborations with multiple partners on drug candidates using Ambrx technology. The company was incorporated in 2003 and is headquartered in La Jolla, California. As of March 7, 2024, Ambrx Biopharma Inc. operates as a subsidiary of Johnson & Johnson.

AMAM Chatroom

User Image Earth4thewin Posted - 2 hours ago

@StockAuthority or like $AMAM

User Image SmallCapMultiplier Posted - 1 day ago

@ElGatoRogo yes, I was sure of $AMAM getting acquired and it got acquired and went up 97% However I was “sure” that LCID would be able to deliver their predictions and guidance they released but they did not and I lost $25,000

User Image DharlMorey2 Posted - 1 week ago

@CARTE_BLANCHE_DEVEREAUX 10+ is where I think it will stabilize given that it ran to 9.82 previously on smaller results. Given that $AMAM ran to 28.00 on a smaller study (1 billion market cap on a phase-1) that would indeed put Atossa to ~10.00 for the same market cap. Atossa has a massive phase-2 with 275 patients due in Q4, another phase-2 for Z-Endoxifen in the I-Spy2 trial, another 80mg trial, and other combination therapies with Eli Lily's drug. I'm hoping SLS pops first to be honest :)

User Image JeffTheOmega1 Posted - 1 month ago

$GOSS Please keep us based .89/.90 Need to wait for $NVDA squeeze to cash out calls to load more dip $GOSS is a LT hold play for me My next $AMAM $SMMT swing to Valhalla

User Image Monica362 Posted - 1 month ago

@SoldDaPopinski @Vaxylove @BGirl @herbbrooks @VXRT_Squirrel @Sunwell @Nik_CA @7xbagger @OptionPapa $AMAM “got bought by $JNJ for $2B after going 1,007% on a Friday. “ Happy Labor s Day

User Image ALATOM0369 Posted - 1 month ago

$OCGN $AMAM got bought by $JNJ for $2B after going 1,007% on a Friday. I’ve personally experience a 900% gain with $HQGE, it’s impressive. I have the feeling that we are going to jump that high, and even higher. Havagooday Bulls.

User Image B1GCityCat Posted - 07/30/24

$AMAM $ATOS $IBRX If they need more patients, should we be concerned? 🤔

User Image Bullishbruk Posted - 07/28/24

$IBRX and $ATOS are bigger than $AMAM which I bought for $1.25 and just not to long ago got BO for $28.00 Made a killing…$$$$$. Been doing this for a few years know a good company when I see one. Patients please! Minimum PT $45 and $26 respectively. GLTL long and strong

User Image tastee435 Posted - 07/24/24

$SILO You are a wise person, not many understand this offering play 👏🏿 ,Still holding...$ALT and $AMAM did the same thing..🚀

User Image tastee435 Posted - 07/23/24

$SILO Loading opportunity, don't miss the boat..! $JNJ ,$AMAM ,$PFE 🚀

User Image DharlMorey2 Posted - 07/22/24

@jajj3a @GPS_OS_21_vs_SOC_5 $TPSTt jumped 2000% in a day, $GLSI 800%, $AMAM around 500% twice in a year, etc. GPS_OS can pump as long as they keep providing facts. Phase-3 data is a big deal imo -- I think we see double-digits. Too much short interest, too many calls open, etc. this will move up fast!

User Image John_D_Stockefeller Posted - 07/22/24

@John___wick44 So sorry for your many losses. My story, with $HARP and $AMAM both getting bought out at a nice premium on the same day, is different.

User Image bej_trades Posted - 07/17/24

@BigSpenderr yeah definitely gives me those vibes. $AMAM was probably my biggest $.30s to $4 in 3 hours. Months later got bought out at $28 / share I was long gone by then tho ha cheers bro! 🍻

User Image DharlMorey2 Posted - 07/16/24

I was able to jump into $CADL late which is what I think SLS is going to do. SLS may in a few months also have more of an $AMAM like buyout sort of deal in the works. Last annual general meeting they said they were actively working with Stifel group to get a partnership in place -- let's see.

User Image John_D_Stockefeller Posted - 3 months ago

@telomerase @Chemaster btw, i was in both $HARP and $AMAM from a couple of bucks, to buyouts well into in the $20s. Have a couple right now that are set up for similar outcomes, imo.

User Image Earth4thewin Posted - 3 months ago

$ZVSA Nothing good comes easy, they had $ZVSA 's sister company $AMAM beat down to .48 cents a share before $JNJ bought them out for 28$ a share 😉👍

User Image BALLTRASHER Posted - 3 months ago

$NUKK $AMAM also your right about mad dark pool volume in the middle of the night, what exactly does that tell us?

User Image BALLTRASHER Posted - 3 months ago

$NUKK $AMAM correct most likely nukk would forward split to match equity as the incoming reverse merger would be the reverse split. My thoughts exactly, no dilution it's reverse merger and up it goes.

User Image bej_trades Posted - 3 months ago

$NUKK almost got shook out yesterday but spidey sensies tell me there’s some mad F’ery with this. I’ve read the sec filings throughly. They can’t dilute with someone else. Last offering was madly discounted but small number of shares. OS still under 5 mil imo. I suspect mad darkpool. Reminds me of $amam $0.30 to $3. To each their own 🍻

User Image TheRealFallen Posted - 3 months ago

$GRTS How did $AMAM folks survive the plunge to $0.20 before BO at $28 well idk their balance sheet was a bit more robust, but market eventually simply recognized the value and forever downtrend finally reversed. Thats why I will ride this to $0.00 and perhaps better evaluate importance of management background and integrity in the future.. atleast have some gains to offset but doesn’t make the loss hurt much less🤔. PCV will be big future of oncology I still firmly believe. Perhaps not from this player in the market. Stay strong friends 🙏💪

User Image Earth4thewin Posted - 3 months ago

@DouglasJanes2025 these bio stocks you just never know, they got $AMAM down to 48 cents a share ,then $JNJ bought them out at $28 per share 🤷 I'm sure alot of people were kicking themselves for selling too early,or not buying in at all ...🙂 I'm

User Image Earth4thewin Posted - 06/25/24

$UNCY don't lose heart , $AMAM was .48 cents before getting bought out by $JNJ for $28 a share 👍🎉

User Image DharlMorey2 Posted - 06/20/24

@OnTheBalance @cb5000calls @Wut_About_Bob I've seen some bios (e.g. $AMAM run from 1 to 7-9 for a few months, then from that range to 28 for buyout). Optics won't matter if they want to make an offer imo, but agreed this will sell for more than 1.50, should be something in the double-digits range :)

User Image Letsgetit80 Posted - 06/19/24

$TPST gives $AMAM vibes Time will tell

User Image DharlMorey2 Posted - 06/19/24

$SLS Enjoy your holiday folks! Some nice DD linked--not worried until we get bad data, buying more shares next payday (at least 100 per troll I block 😂). Let's see if management gives more info Thursday. They gotta get board of directors voted on first on Thursday before they release any more good juice though🙂 Call buying here remains extremely elevated -- very interesting! 🤔 $XBI $BKNG $CADL $AMAM

User Image Earth4thewin Posted - 06/17/24

If you helped $AMAM go from below .50 cents to over $28 surely you can help $ZVSA do just as good if not better 🙌

User Image DharlMorey2 Posted - 4 months ago

$SLS 13,000C contracts at 1.50 (In the money) for Sept -- 26,000 total Call contracts at near and long term sold today. - We had around 18,000 contracts traded past two days. - Normal day usually around a few hundred - Big Bio move coming, reminds me of $CADL and $AMAM more recently. $XBI

User Image Earth4thewin Posted - 4 months ago

@yada010 it will probably get bought out like $zvsa was by $JNJ . Seeing AMBRX soar from below .50 cents to $28 was amazing 🎉⏰ $ZVSA and $AMAM are supposed to be sister companies, I'm hoping $JNJ picks up both ✅🤞

User Image John_D_Stockefeller Posted - 4 months ago

@Earth4thewin true. I was in $AMAM, from the 2s and 3s. Don‘t forget the r/s here. At least one, and offering(s?).

User Image John_D_Stockefeller Posted - 4 months ago

@jcooptechit Welp, not always true. I bought, added to, and held both $AMAM and $HARP through a period of about 15 months. Both endured severe ups and downs, and HA RP had a reverse split along the way. i got in early, and they both got bought out in January. Made a tidy sum on both. Many small would do fine, continue to grow and prosper…..if day traders and flippers jumped off a cliff.

Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Nelson Sonja Chief Financial Offi.. Chief Financial Officer Oct 27 Sell 9.82 12,778 125,480 130,079 10/31/23
O'Connor Daniel J. President and CEO President and CEO Oct 27 Sell 9.82 50,012 491,118 342,845 10/31/23
Cormorant Asset Management, LP 10% Owner 10% Owner Oct 23 Buy 6.9911 1,307,311 9,139,542 11,231,000 10/25/23
Cormorant Asset Management, LP 10% Owner 10% Owner Sep 15 Buy 9.15 2,152,738 19,697,553 69,465,823 09/19/23
Cormorant Asset Management, LP 10% Owner 10% Owner Apr 18 Buy 11.34 5,215,189 59,140,243 67,313,085 04/20/23
Cormorant Asset Management, LP 10% Owner 10% Owner Apr 13 Buy 9.93 2,597,896 25,797,107 62,097,896 04/17/23